Biogen’s Alzheimer’s drug could generate ‘$8 billion in peak sales’: Analyst

Yahoo Finance published this video item, entitled “Biogen’s Alzheimer’s drug could generate ‘$8 billion in peak sales’: Analyst” – below is their description.

#Biogen #alzheimers #yahoofinance

Mizuho Americas Senior Biotech Analyst Salim Syed joins Yahoo Finance Live anchors Julie Hyman and Brad Smith to discuss encouraging Phase 3 data from Biogen’s Alzheimer’s treatment lecanemab, how many sales the drug could generate, and what this means for the pharmaceutical industry.

Yahoo Finance YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.


Leave a Comment

We don't require your email address, or your name, for anyone to leave a comment. If you do add an email address, you may be notified if there are replies to your comment - we won't use it for any other purpose. Please make respectful comments, which add value, and avoid personal attacks on others. Links are not allowed in comments - 99% of spam comments, attempt to post links. Please describe where people may find additional information - for example "visit the UN website" or "search Google for..." rather than posting a link. Comments failing to adhere to these guidelines will not be published.